Review Article
Regulation of MicroRNAs by Natural Agents: New Strategies in Cancer Therapies
Table 1
Clinical trials involving selected natural agents.
| Natural agent | Trial identifier | Phase | Cancer type | Status |
| Curcumin | NCT01042938 | 2 | Breast | Completed | NCT00094445 | 2 | Pancreatic | Completed | NCT00192842 | 2 | Pancreatic | Completed | NCT01333917 | 1 | Colorectal | Completed | NCT00027495 | 1 | Colorectal | Completed | NCT01035580 | 1 | Uterine cervical | Completed | NCT00113841 | n.a | Multiple myeloma | Completed | NCT01975363 | n.a | Breast | Active | NCT01859858 | 1 | Colorectal | Active | NCT00745134 | 2 | Rectal | Active | NCT01294072 | 1 | Colon | Active | NCT01917890 | n.a | Prostate | Active | NCT01160302 | 0 | Head and neck | Active | NCT01490996 | 1/2 | Colon | Active | NCT02095717 | 2 | Prostate | Active | NCT02017353 | 2 | Endometrial | Active | NCT02064673 | 2 | Prostate | Active | NCT00641147 | n.a | Familial adenomatous Polyposis | Active | NCT00927485 | n.a | Familial adenomatous Polyposis | Active | NCT01948661 | 2 | Colorectal | Active |
| Resveratrol | NCT00256334 | 1 | Colon | Completed | NCT00433576 | 1 | Colorectal | Completed | NCT00098969 | 1 | Solid tumours | Completed | NCT01476592 | n.a | Neuroendocrine | Active |
| Genistein | NCT00244933 | 2 | Breast | Completed | NCT00118040 | 2 | Bladder | Completed | NCT00099008 | 1 | Breast | Completed | NCT00584532 | 2/3 | Prostate | Completed | NCT00376948 | 2 | Pancreatic | Completed | NCT00269555 | n.a | Prostate | Completed | NCT00499408 | 2 | Prostate | Completed | NCT00078923 | 2 | Prostate | Completed | NCT01985763 | 1/2 | Colorectal | Active | NCT01325311 | 2 | Prostate | Active | NCT01126879 | 2 | Prostate | Active | NCT01628471 | 1/2 | Lung | Active | NCT00276835 | 0 | Kidney; melanoma | Active | NCT01182246 | 1/2 | Pancreatic | Active |
| EGCG | NCT00459407 | 1 | Prostate | Completed | NCT00233935 | 1 | Esophageal | Completed | NCT00573885 | 2 | Lung | Completed | NCT00303823 | 2 | Cervical | Completed | NCT01105338 | 2/3 | Prostate | Completed | NCT00516243 | 1 | Breast | Active | NCT00942422 | 2 | Multiple myeloma | Active | NCT00596011 | 2 | Prostate | Active | NCT01606124 | 2 | Colorectal | Active | NCT00253643 | n.a | Prostate | Active | NCT00917735 | 2 | Breast | Active | NCT01360320 | 2 | Colorectal | Active | NCT00949923 | 1 | Breast | Active |
| I3C | NCT00607932 | n.a | Prostate | Completed | NCT00033345 | 1 | Breast | Completed | NCT00100958 | 1 | Solid tumours | Completed |
| DIM | NCT00450229 | 1 | Prostate | Completed | NCT00305747 | 1 | Prostate | Completed | NCT00462813 | 3 | Cervical | Completed | NCT00888654 | 2 | Prostate | Active | NCT01391689 | 2/3 | Breast | Active |
|
|